Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhFSH in infertile men with oligospermia undergoing ICSI evaluation
IRCT20170923036334N2Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of recombinant human follicle stimulating hormone in male infertility and oligospermia (2 arms), sponsored by Islamic Azad University. Primary endpoints: Sperm parameters, DNA damage and 3 more. Started Feb 2018; status: completed.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
male infertilityoligospermia
Beyond the preview
Go deeper on IRCT20170923036334N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170923036334N2.